Deutsche Bank set a €25.00 ($29.07) price objective on AXA (EPA:CS) in a research note published on Friday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
CS has been the subject of a number of other reports. HSBC dropped their price objective on shares of Canada Goose from C$62.00 to C$55.00 and set a buy rating for the company in a research note on Monday, June 3rd. Royal Bank of Canada reissued a sector perform rating and set a GBX 485 ($6.34) price objective on shares of in a research note on Tuesday, July 9th. Goldman Sachs Group reissued a hold rating and set a $8.40 price objective on shares of Deutsche Bank in a research note on Monday, July 8th. Barclays raised their price objective on shares of Zimmer Biomet from $113.00 to $117.00 and gave the stock an underweight rating in a research note on Monday, April 15th. Finally, JPMorgan Chase & Co. began coverage on shares of Pinduoduo in a research note on Tuesday, July 9th. They set an underweight rating and a $20.48 price objective for the company. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. AXA has an average rating of Buy and a consensus price target of €26.56 ($30.89).
Shares of CS opened at €23.66 ($27.51) on Friday. The stock’s 50 day simple moving average is €22.87. AXA has a 1-year low of €22.13 ($25.73) and a 1-year high of €27.69 ($32.20).
AXA Company Profile
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
See Also: Why Dividend Stocks May Be Right for You
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.